Bank of America has taken a sharper turn on Alcon , issuing a double downgrade that shifts the Swiss eye-care group from buy ...

Adds STAAR Surgical comment. STAAR Surgical (STAA) dropped 5% after proxy adviser Glass Lewis recommended holders reject the ...

STAAR Surgical's major shareholder intends to vote against the acquisition, stating the price still significantly undervalues ...

(Corrects paragraph 5 to clarify vote has been postponed for third time, not previously postponed three times) By Maria ...

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced that it has ...

STAAR Surgical ( STAA) soared 10% after Alcon ( ALC) increased its offer for STAAR to $30.75/share in cash. The purchase ...

Alcon announced that it entered into an amended merger agreement for its planned acquisition of Staar Surgical.

Alcon increases its acquisition offer for STAAR Surgical, emphasizing a final deal amid shareholder debates and delays in the ...

Major STAAR shareholders reject Alcon's increased $30.75 bid, citing a flawed sale process, insufficient valuation, and ...

Alcon raises its Staar Surgical bid to $1.6B amid shareholder opposition, with a December 19 vote scheduled for acquisition.

Investing.com -- Bank of America double downgraded Alcon to Underperform and cut its price objective to 60 CHF from 80 CHF, citing weaker visibility on growth and a slower than expected ramp in Unity ...